Track Paragon 28, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Paragon 28, Inc. FNA · Stock Open Paragon 28, Inc. in new tab

13.09 USD
EPS
-0.66
P/B
8.41
ROE
-36.39
Beta
1.47
Target Price
15.00 USD
Loading chart...
Key Metrics
EPS-0.66
Book Value1.56
Price to Book8.41
Debt/Equity86.22
% Insiders31.215%
Growth
Revenue Growth0.19%
Estimates
Forward P/E-27.85
Forward EPS-0.47
Target Mean Price15.00

DCF valuation

Model fair value for Paragon 28, Inc. (FNA)
Result
Sign in to run the valuation for FNA.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 15.00 USD (low 12.00, high 20.00)
Low 12.00
Mean 15.00
High 20.00
Price 13.09
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Paragon 28, Inc. Logo Paragon 28, Inc. Analysis (FNA)

Is Paragon 28, Inc. a good investment? Paragon 28, Inc. (FNA) is currently trading at 13.09 USD. Market analysts have a consensus price target of 15.00 USD. This suggests a potential upside from current levels.

Investor FAQ

Does Paragon 28, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Paragon 28, Inc.?

Paragon 28, Inc. is classified as a Stock.

Company Profile

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair system, and phantom fibula nail system. It also provides flatfoot systems, such as gorilla universal plating system, JAWS great white staple system, monster screw system, grappler suture anchor system, and mister tendon harvester system; ankle replacement system consists of metallic and plastic implant components, as well as ankle fusion plating system and phantom hindfoot nailing system; Charcot systems, including the joust beaming system, gorilla medial column plating system, and monkey rings external fixation system; and orthobiologics products, such as V92 cellular bone matrix, PRESERVE bone wedges, MgNum bone void filler, and BEAST demineralized bone matrix. The company serves hospitals, ambulatory surgery centers, and health care facilities through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado. As of April 21, 2025, Paragon 28, Inc. operates as a subsidiary of Zimmer Biomet Holdings, Inc.

Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion